18 results
8-K
EX-10.4
td5xnhra qr
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
8-K
EX-10.1
1exc0z
2 Dec 19
Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy
7:52am
424B4
n63dn7i24eis2
5 Nov 14
Prospectus supplement with pricing info
12:00am
S-1/A
EX-10.4
qyoam v50tlod3v
6 Oct 14
IPO registration (amended)
12:00am
S-1/A
EX-10.5
e8pk puq5bmdr
6 Oct 14
IPO registration (amended)
12:00am
S-1/A
dnmxk3nu
6 Oct 14
IPO registration (amended)
12:00am
S-1/A
EX-10.2
azqfzg5
6 Oct 14
IPO registration (amended)
12:00am
DRS/A
vo3s6oijj5xozaxt00
19 Mar 14
Draft registration statement (amended)
12:00am
DRS/A
0zv m6fsbm
25 Sep 13
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next